Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Treatment Use of 3,4-Diaminopyridine

Expanded access is currently available for this treatment.
Verified April 2014 by Duke University
Sponsor:
Information provided by (Responsible Party):
Vern C. Juel, M.D., Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT01765140
First received: January 6, 2013
Last updated: April 27, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is currently available for this treatment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given